Deutsche Märkte schließen in 1 Minute

Tandem Diabetes Care, Inc. (TNDM)

NasdaqGM - NasdaqGM Echtzeitpreis. Währung in USD
Zur Watchlist hinzufügen
136,98-5,51 (-3,87%)
Ab 04:00PM EST. Markt geöffnet.
Melden Sie sich an, um eine Nachricht zu posten.
  • W
    Wall St.
    $SENS conversation
    Given, that $KKR did involved in investing and marketing $SENS. Future looks progressive. As A Private Equity Fund. KKR buys stake in company or whole company, then leverages it with bank's money. Then creates cash flow and sells it at huge primiums, debt included. That's how the capitalize their knowledge.
    They usually hold company for 5 to 7 years. In that time frame, they will market the product, and sell it's stake 8n the company or the whole company. My hunch is $40 to $50
    Sens will worth it. This is just the beginning. Start accumulation below $1 and hold it. This one will be a winner as is $TNDM
  • W
    Wall St.
    $SENS conversation
    $Sens said that revenue in Quarter will go up, henceforth pop on the stock. It is about time. Great technology. I rember $TNDM going from $2 to over $115. Hope same will happen with Senseonics. Phoenix, rise from the ashes 😂
  • a
    alanb
    $TNDM conversation
    $TNDM turns profitable with increasing gross margins!
  • W
    Wall St.
    $SENS conversation
    This is the strange company. Since it got DDA approval for 90 days. Stock was halted at circa $5 went up next day to $5.29. every one thought it would be next $TNDM But stock, started descending slowly and gradually to as low as circa $0.35
    Now it 9s $0.45. $SENS has a great product, yet market doesn't like it.
    Amazing. My hunch is it may survive, it is a delusional thought. Yet time will tell. It makes lower highs and lower lows. Technically, it is not healthy long wise.
    Look at $TNDM & $DXCM
    I am accumulating and treating it as a long term oppion, price wise. It is at will of miracle. Aristotle, said: For every impossibility, there's possibility. In this case Improbable may become probable. Long story short, great product. Yet MR Market, hates it. I hope for the best.yet this company 8s on respirator. LoL Dear God, make the $SENS profitable 😃
    Cheers to all suffocating Longs.
  • r
    ridingbreakouts
    $VLRX conversation
    10,000 shares in $TNDM Tandem Diabetes about 18 months ago would be worth $700,000. Extraordinary. When it went from $10 to $2.50 down 75% message board ppl said poor cash flow, too much competition, might go B/K, on and on. $VLRX in 18 months can easily roar 500% to 1000%. Bargain. Dirt cheap. Market cap $18 mil. Sure. Type 2 NICHE is enormous. USA and globally for patient care. 18 months let us see where this stock is. North of $20/shr
  • k
    keyur
    $TNDM conversation
    someone on ST just posted -

    $TNDM Just got this email from Tandem

    Join us Wednesday, January 15 at 4 PM EST/ 1 PM PST for a live presentation featuring Danielle Karsten, Director of Product Marketing at Tandem Diabetes Care. Danielle will be giving an overview of Control-IQ™ technology, as well as outlining the process of getting it for both new customers and current t:slim X2™ insulin pump users.

    The event will be moderated by Marketing Manager Christopher Angell, and will be followed by a live Q&A. If you are unable to join the live event, a recording will be available in the Videos section of Tandem’s Facebook page shortly afterwards.
  • M
    Maxwell
    I am looking forward to Sept. 25th (institutional investor day) when initial international sales models are expected. Canada continues to be an elusive market at the moment. The $DXCM acquisition of TypeZero is extremely bullish news for $TNDM. As insurance cycles in Q4 I’m looking for strong sales and perhaps an $MDT conversion rate please...Kim

    holy grail: UHC coverage —> $DXCM merger (?)
  • M
    Maxwell
    I guess we will continue to limp into 25OCT until otherwise reflected by the share price.

    The market seems intent on not letting growth names breakout to new highs.

    No intention of selling on any dip here short term. $2B valuation is fair for $TNDM at this moment but I expect we contend with $PODD for comparable valuation by 2020. Revenue growth is what everyone expects...to what degree remains to be seen. I believe in a possibility of new markets unlocked in Canada and through UHC/$UNH... no stock is invincible but if the company in which you own equity is growing revenues, I suppose the share price will have to reflect that sooner or later. If you can afford to hold your shares, I would. If you can add more through the coming 18months, I would.

    To those that lost, you have Jeff Johnson at Baird to thank for the correction. I actually think Jeff Johnson’s “downgrade” will be seen as a good thing for long term valuations (assuming the market allows for that type of thing)
  • M
    Maxwell
    There was a question about manufacturing capacity a couple days ago that got me interested in the topic...

    The most accurate info about manufacturing capacity I could find:

    https://www.businesswire.com/news/home/20180301006453/en/Tandem-Diabetes-Care-Announces-2017-Financial-Results

    http://investor.tandemdiabetes.com/news-releases/news-release-details/tandem-diabetes-care-commences-full-manufacturing-operations-new

    I should point out that the cash raised during the secondary offering in August was used to pay down a loan taken out to cover the cost of their new manufacturing facility.

    In 2017 $TNDM shipped ~17K pumps from their old facility. According to Q1/2 2018 reports $TNDM shipped ~10K pumps from their new facility (Q3/4 2018 should push the total number well over 25K pumps shipped). If we take at face value their claim that they’ve doubled manufacturing space and improved efficiencies my conservative estimate for annual pump manufacturing capacity is 40K. I would love to hear Kim address specifically where that capacity is during Q3 2018 conference call (25OCT) but I doubt he will be forthcoming with that info as it doesn’t account for the entire 2018 fiscal year. I hope my math is ok here but it’s truly just my best guess. Good luck!
    Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United St
    Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United St
    www.businesswire.com
  • S
    Super Trader
    $DXCM conversation
    $TNDM is coming rock solid behind DXCM.
  • r
    ridingbreakouts
    TNDM went up over 3,000% in 3 years. Same niche. SENS BULL $TNDM $SENS $DXCM
  • r
    ridingbreakouts
    TANDEM went up over 2,300% in under 9 months. The market cap of VLRX is WAY TOO LOW. BARGAIN. $5 then $10 then $15++. $tndm $vlrx
  • r
    ridingbreakouts
    Idea board. Take it from me I was in TNDM at $6.75 then it went down 60% more. I held on and sold in the mid $40’s gain of almost 600%. The market cap in the $2.90 range was A BARGAIN. I missed the high in the $70’s. VLRX $1.65 type 2 diabetes similar formation occurring. Similar reverse split, margin expansion, increasing sales, larger salesforce, approvals, etc $tndm $vlrx
  • r
    ridingbreakouts
    $VLRX conversation
    $12 million market cap. BARGAIN. Revenue of approx. $30 mil+ in revenue in 2019. $35-$40 mil in year 2020. Margins increasing, contracts increasing, sales reps targeting globally.
    I see this going to $10-$15 per share minimum. Trading firm shorts cannot take it down forever. Value play all day.
    They took $TNDM down 95% before taking it 2,000%+ higher
  • B
    Bryan Miller
    $TNDM conversation
    What made $TNDM tank?
  • r
    ridingbreakouts
    Valeritas VLRX. CBD. BOOM. Good luck shorts. Market cap should be $50 mil BARE MINIMUM or 300% higher. Type 2 diabetes V-Patch Global revenue 2019 greater than $30 million. 2020 should near $40 million. $tndm $dxcm $vlrx
  • a
    alanb
    $DXCM conversation
    Why is $DXCM so down today? My guess it is the $TNDM and ABT news. Analysts and auto-trading sometimes are so lost. Dexcom CGM accuracy over Abbott Libre FGM is very different accuracy. Great for existing ABT users to be able to use t:slim pump but it's not going to cause folks to switch off of DXCM G6/G7. Positive news for TNDM and ABT. That's it.

    Abbott and Tandem Diabetes Care Exploring New Integrated Solutions to Improve Diabetes Management
    https://finance.yahoo.com/news/abbott-tandem-diabetes-care-exploring-120000847.html
  • S
    Super Trader
    $TNDM conversation
    Rock solid $TNDM moving forward to reach 300.00. Here and there a little pause, that is ok. She will get there.
  • A
    AIKIDO
    Thank you SAM for the update revenues RX growth accelerates to new high every week, Imagine what the Diabetes community as Dr Busch said hundreds of patients are now in Vascepa, total explosions in sales Could jump 1000% , Like $DXCM and $TNDM and also $MDT , wow $AMRN rocket to $300 in 3 years
  • D
    Denny
    $TNDM conversation
    Are you absolutely positively sure of that Goldie Chains?

    Mr_Tandem
    21m
    $TNDM I'm not going anywhere. I'm going to continue sharing FACTUAL information with the shareholders I feel have the same interest in Tandem Diabetes succeeding as I do. This is WAY more than a financial play. This is a company clawing it's way back from the brink - against all odds (as the shorts of 2018 found out the hard way) and they're gaining traction against their competition by the day. Superior products, superior customer service and superior management team. This is the ultimate buy/hold proposition for long term shareholder value. So yeah - I'm not leaving.